Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Not stated	2024-12-02		NCT05598528

47 results · Page 1 of 2

Swipe the table sideways for more columns.

Organizations	Linked trials
Changde Hospital, Xiangya School of Medicine, Central South University	3
Changsha Central Hospital	6
Changsha First Hospital	3
Changsha Third Hospital	3
China-Japan Friendship Hospital	135
First Affiliated Hospital of Guangxi Medical University	96
First Affiliated Hospital of Kunming Medical University	31
First People's Hospital of Chenzhou	9
Fudan University	653
Guiyang Public Health Treatment Center	1
Hengyang Central Hospital	4
Huaihua first people's Hospital	1
Hunan Academy of Traditional Chinese Medicine Affiliated Hospital	1
Hunan Cancer Hospital	66
Hunan Provincial People's Hospital	23
Hunan Provincial Straight Hospital of Traditional Chinese Medicine	1
Hunan Shaoyang Central Hospital	4
Liuyang Hospital of traditional Chinese Medicine	1
Loudi Central Hospital	8
People's Hospital of Zhangjiajie	1
Renmin Hospital of Wuhan University	73
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
Second People's Hospital Of Huaihua	1
Second People's Hospital of Hunan	2
Second Xiangya Hospital of Central South University	95

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Oncology, The Second Xiangya Hospital, Central South University	Changsha	China	4

Clinical trials